Silexion Therapeutics Corp business relationships

Companies named in Silexion Therapeutics Corp’s 10-K filed 2026-03-17, and public companies whose annual reports name Silexion Therapeutics Corp. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.

Open on the map Full AI visibility profile

AEO visibility: 4.7 / 10
AI naming: 22 / 100
Agent readiness: 25 / 100
AI adoption: 0 / 100

Named in Silexion Therapeutics Corp’s annual report 6

ASTRAZENECA PLC (AZN)Partner7.7
“Other companies with selective KRAS inhibitors include AstraZeneca (in collaboration with Usynova), BioNTech, Roche, Merck/Moderna, Boehringer and Gilead.” SEC filing
GILEAD SCIENCES, INC. (GILD)Partner7.7
“Other companies with selective KRAS inhibitors include AstraZeneca (in collaboration with Usynova), BioNTech, Roche, Merck/Moderna, Boehringer and Gilead.” SEC filing
Merck & Co., Inc. (MRK)Partner7.7
“Other companies with selective KRAS inhibitors include AstraZeneca (in collaboration with Usynova), BioNTech, Roche, Merck/Moderna, Boehringer and Gilead.” SEC filing
Roche GroupPartner7.7
“Other companies with selective KRAS inhibitors include AstraZeneca (in collaboration with Usynova), BioNTech, Roche, Merck/Moderna, Boehringer and Gilead.” SEC filing
BioNTech SE (BNTX)Partner6.1
“Other companies with selective KRAS inhibitors include AstraZeneca (in collaboration with Usynova), BioNTech, Roche, Merck/Moderna, Boehringer and Gilead.” SEC filing
Moderna, Inc. (MRNA)Partner6.1
“Other companies with selective KRAS inhibitors include AstraZeneca (in collaboration with Usynova), BioNTech, Roche, Merck/Moderna, Boehringer and Gilead.” SEC filing

Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.